CPB vs EBS
Campbell’s Co (CPB) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. Revenue was up 6.4% from 2024-07-28 to 2025-08-03. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CPB and EBS stock pages for the full models.
Not investment advice.